Advances in pediatrics in 2014: current practices and challenges in allergy, gastroenterology, infectious diseases, neonatology, nutrition, oncology and respiratory tract illnesses

Italian Journal of Pediatrics

Sergio Bernasconi²  Carlotta Povesi-Dascola¹  Elisa Sciorio³  Silvia Cesari¹  Francesca Santamaria³  Carlo Caffarelli¹ 

[1] Clinica Pediatrica, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy;Pediatrics Honorary Member University Faculty, “G D’ Annunzio” University of Chieti Pescara, Chieti, Italy;Department of Translational Medical Sciences, Federico II University, Naples, Italy

关键词: Respiratory tract illnesses;    Oncology;    Nutrition;    Neonatology;    Infectious diseases;    Gastroenterology;    Allergy;   

Others  :  1232052
DOI  :  10.1186/s13052-015-0193-8

 received in 2015-09-28, accepted in 2015-10-20,  发布年份 2015

【 摘 要 】

Major advances in the conduct of pediatric practice have been reported in the Italian Journal of Pediatrics in 2014. This review highlights developments in allergy, gastroenterology, infectious diseases, neonatology, nutrition, oncology and respiratory tract illnesses. Investigations endorse a need to better educate guardians and improve nutritional management in food allergy. Management of hyperbilirubinemia in neonates and of bronchiolitis have been improved by position statements of scientific societies. Novel treatments for infant colic and inflammatory bowel diseases have emerged. Studies suggest the diagnostic utility of ultrasonography in diagnosing community-acquired pneumonia. Progress in infectious diseases should include the universal varicella vaccination of children. Recommendations on asphyxia and respiratory distress syndrome have been highlighted in neonatology. Studies have evidenced that malnutrition remains a common underestimated problem in developing countries, while exposure to cancer risk factors in children is not negligible in Western countries. Advances in our understanding of less common diseases such as cystic fibrosis, plastic bronchitis, idiopathic pulmonary hemosiderosis facilitate diagnosis and management. Researches have led to new therapeutic approaches in patent ductus arteriosus and pediatric malignancies.

【 授权许可】

   
2015 Caffarelli et al.

【 参考文献 】

• [1]Caffarelli C, Coscia A, Ridolo E, Povesi Dascola C, Gelmetti C, Raggi V, et al.: Parents’ estimate of food allergy prevalence and management in Italian school-aged children. Pediatr Int 2011, 53:505-510.
• [2]Robbins KA, Wood RA, Keet CA: Milk allergy is associated with decreased growth in US children. J Allergy Clin Immunol 2014, 134:1466-1468.
• [3]Giovannini M, D’Auria E, Caffarelli C, Verduci E, Barberi S, Indinnimeo L, et al.: Nutritional management and follow up of infants and children with food allergy: Italian Society of Pediatric Nutrition/Italian Society of Pediatric Allergy and Immunology Task Force Position Statement. Ital J Pediatr 2014, 40:1. BioMed Central Full Text
• [4]Chau K, Lau E, Greenberg S, Jacobson S, Yazdani-Brojeni P, Verma N, et al.: Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 2015, 166:74-78.
• [5]Sung V, Hiscock H, Tang MLK, Mensah FK, Nation ML, Satzke C, et al.: Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial as. BMJ 2014, 348:g2107.
• [6]Savino F, Ceratto S, De Marco A, Cordero di Montezemolo L: Looking for new treatments of Infantile Colic. Ital J Pediatr 2014, 40:53. BioMed Central Full Text
• [7]Jostins L, Ripke S, Weersma RK, et al.: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
• [8]Caffarelli C, Bernasconi S: Preventing necrotising enterocolitis with probiotics. Lancet 2007, 369:1578-1580.
• [9]Comito D, Cascio A, Romano C: Microbiota biodiversity in inflammatory bowel disease. Ital J Pediatr 2014, 40:32. BioMed Central Full Text
• [10]Salas AA, Nava A: Acute cerebellar ataxia in childhood: initial approach in the emergency department. Emerg Med J 2010, 27:956-957.
• [11]Bozzola E, Bozzola M, Tozzi A, Calcaterra V, Longo D, Krzystofiak A, et al.: Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr 2014, 40:57. BioMed Central Full Text
• [12]Goldmann GS: Cost–benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes–zoster epidemiology. Vaccine 2005, 23:3349-3355.
• [13]Reissig A, Görg C, Mathis G: Transthoracic sonography in the diagnosis of pulmonary diseases: a systematic approach. Ultraschall Med 2009, 30:438-454.
• [14]Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P, et al.: Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest 2012, 142:965-972.
• [15]Esposito S, Papa S, Borzani I, Pinzani R, Giannitto C, Consonni D, et al.: Performance of lung ultrasonography in children with community-acquired pneumonia. Ital J Pediatr 2014, 40:37. BioMed Central Full Text
• [16]Medjo B, Atanaskovic-Markovic M, Radic S, Nikolic D, Lukac M, Djukic S: Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr 2014, 40:104. BioMed Central Full Text
• [17]Qu J, Gu L, Wu J, Dong J, Pu Z, Gao Y, et al.: Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis 2013, 13:172. BioMed Central Full Text
• [18]Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia. Cochrane Database Syst Rev 2012, 10:CD009175.
• [19]Golubnitschaja O, Yeghiazaryan K, Cebioglu M, Morelli M, Herrera-Marschitz M: Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care. EPMA J 2011, 2:197-210.
• [20]Aslam H, Saleem S, Afzal R, Iqbal U, Saleem S, Shaikh M, et al.: Risk factors of birth asphyxia. Ital J Pediatr 2014, 40:94. BioMed Central Full Text
• [21]Yego F, D’Este C, Byles J, Nyongesa P, Williams JS: A case–control study of risk factors for fetal and early neonatal deaths in a tertiary hospital in Kenya. BMC Pregnancy Childbirth 2014, 14:389. BioMed Central Full Text
• [22]Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D: Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011, 128:e1618-e1621.
• [23]Terrin G, Conte F, Scipione A, Bacchio E, Conti MG, Ferro R, et al.: Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr 2014, 40:21. BioMed Central Full Text
• [24]Dang D, Wang D, Zhang C, et al.: Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS ONE 2013, 8:e77888.
• [25]Oncel MY, Yurttutan S, Erdeve O, et al.: Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014, 164:510-514.
• [26]Afaf AK, Alyaa A, Ragaa M, Noha MH: Impact of kangaroo mother care on cerebral blood flow of preterm infants. Ital J Pediatr 2014, 40:83. BioMed Central Full Text
• [27]Conde-Agudelo A, Díaz-Rossello JL: Kangaroo mother care to reduce morbidity and mortality in low birthweight infants. Cochrane Database Syst Rev 2014, 4:CD002771.
• [28]Seidman G, Unnikrishnan S, Kenny E, Myslinski S, Cairns-Smith S, Mulligan B, et al.: Barriers and enablers of kangaroo mother care practice: a systematic review. PLoS One 2015, 10:e0125643.
• [29]Bhutta ZA, Salam RA: Global nutrition epidemiology and trends. Ann Nutr Metab 2012, 61(Suppl 1):19-27.
• [30]Manyike PC, Chinawa JM, Ubesie A, Obu HA, Odetunde OI, Chinawa AT: Prevalence of malnutrition among pre-school children in, South-east Nigeria. Ital J Pediatr 2014, 40:75. BioMed Central Full Text
• [31]Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al.: Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013, 3(382):427-451.
• [32]Howlader N, Noone A, Krapcho M, Garshell J, Miller D, Altekreuse SF, et al.: SEER Cancer Statistics Review, 1975–2011. National Cancer Institute, Bethesda, MD; 2014.
• [33]Magnani C, Mattioli S, Miligi L, Ranucci A, Rondelli R, Salvan A, et al.: SETIL: Italian multicentric epidemiological case–control study on risk factors for childhood leukaemia, non Hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in Italy. Ital J Pediatr 2014, 40:103. BioMed Central Full Text
• [34]Spector LG, Pankratz N, Marcotte EL: Genetic and nongenetic risk factors for childhood cancer. Pediatr Clin North Am 2015, 62:11-25.
• [35]American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis: Diagnosis and management of bronchiolitis Pediatrics 2006, 118:1774-1793.
• [36]Ralston SL, Lieberthal AS, Meissner HC, Alverson BK, Baley JE, Gadomski AM, et al.: Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014, 134:e1474-e1502.
• [37]Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A, et al.: Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr 2014, 40:65. BioMed Central Full Text
• [38]Languepin J, Scheinmann P, Mahut B, Le Bourgeois M, Jaubert F, Brunelle F, et al.: Bronchial casts in children with cardiopathies: the role of pulmonary lymphatic abnormalities. Pediatr Pulmonol 1999, 28:329-336.
• [39]Colaneri M, Quarti A, Pozzi M, Gasparini S, Carloni I, de Benedictis F: Management of plastic bronchitis with nebulized tissue plasminogen activator: another brick in the wall. Ital J Pediatr 2014, 40:18. BioMed Central Full Text
• [40]Costello JM, Steinhorn D, McColley S, Gerber ME, Kumar SP: Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. Pediatrics 2002, 109:e67.
• [41]Bakalli I, Kota L, Sala D, Celaj E, Kola E, Lluka R, et al.: Idiopathic pulmonary hemosiderosis - a diagnostic challenge. Ital J Pediatr 2014, 40:35. BioMed Central Full Text
• [42]Siu KK, Li R, Lam SY: Unexplained childhood anaemia: idiopathic pulmonary hemosiderosis. Hong Kong Med J 2015, 21:172-174.
• [43]Saeed MM, Woo MS, MacLaughlin EF, Margetis MF, Keens TG: Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest 1999, 116:721-725.
• [44]Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS: Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group: Patient reported outcomes: instrument development and selection issues. Value Health 2007, 10(supp):S86-S93.
• [45]Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB: Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009, 135:1610-1618.
• [46]Bodnar R, Kadar L, Holics K, Ujhelyi R, Kovacs L, Bolbas K, et al.: Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis. Ital J Pediatr 2014, 40:50. BioMed Central Full Text